InChI=1S/C52H94N2O10/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-30-37-47(58)54-43(41-63-52-51(62)50(61)49(60)45(40-55)64-52)48(59)44(56)36-32-38-46(57)53-39-31-25-24-27-33-42-34-28-26-29-35-42/h26,28-29,34-35,43-45,48-52,55-56,59-62H,2-25,27,30-33,36-41H2,1H3,(H,53,57)(H,54,58)/t43-,44+,45+,48-,49-,50-,51+,52-/m0/s1 |
CDZMLEFFZGLIAZ-PWIBDSRESA-N |
CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCC(=O)NCCCCCCC1=CC=CC=C1 |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
View more via ChEBI Ontology
Outgoing
|
(5R,6S,7S)-5,6-dihydroxy-8-(α-D-galactosyloxy)-7-hexacosanamido-N-(6-phenylhexyl)octanamide
(CHEBI:166879)
has role
epitope
(CHEBI:53000)
(5R,6S,7S)-5,6-dihydroxy-8-(α-D-galactosyloxy)-7-hexacosanamido-N-(6-phenylhexyl)octanamide
(CHEBI:166879)
is a
α-galactosylsphingamide
(CHEBI:139111)
|
|
(5R,6S,7S)-8-(α-D-galactopyranosyloxy)-7-hexacosanamido-5,6-dihydroxy-N-(6-phenylhexyl)octanamide
|
(5R,6S,7S)-5,6-dihydroxy-7-hexacosanamido-8-(α-D-galactosyloxy)-N-(6-phenylhexyl)octanamide
|
ChEBI
|
α-GSA[26,6P]
|
ChEBI
|
N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]hexacosanamide
|
PDBeChem
|
31391251
|
PubMed citation
|
Europe PMC
|
|